1
Pediatric and Congenital Cardiology Division, Pediatric Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran.
2
Congenital and Pediatric Cardiology Division, Pediatric Department, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran.
3
Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, IR Iran.
Abstract
Respiratory symptoms constitute one of the most significant manifestations of the coronavirus infection. SARS-CoV-2 (COVID-19) may lead to a life-threatening condition called “multisystem inflammatory syndrome in children (MIS-C),” which can affect many organs and systems, such as cardiovascular, respiratory, gastrointestinal, and renal systems. The condition might lead to severe and irreversible damage.
Myocarditis is one of the presentations of COVID-19 in children. Cardiac tissue inflammation could enhance the automaticity of cells and develop different arrhythmias.
Here, we report a pediatric case of MIS-C with cardiac involvement inducing atrial tachycardia and sinus node dysfunction. (Iranian Heart Journal 2024; 25(2): 96-101)
Hemali P. Shah, Richard Frye, Sunny Chang, Erin Faherty, Jeremy Steele, and RuchikaKarnik, Challenges of Diagnosing Viral Myocarditis in Adolescents in the Era of COVID-19 and MIS-C, Hindawi,Case Reports in Pediatrics,Volume 2021, Article ID 4797498, 7 pages
Saagar K. Sanghvi, Logan S. Schwarzman and Noreen T. Nazir: Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis, Diagnostics 2021, 11, 130
Feisal Rahimpour, Mohsen Yaghubi, Reza Ghasemi and Mahmood Hosseinzadeh Maleki, Complete Atrioventricular Block Complicated with Cardiogenic Shock as Primary Manifestation of a Novel Coronavirus Infection in a Child: A Rare Case Report, Iran Red Crescent Med J. 2021 June; 23(6):e672
Eveline Y. Wu and M. Jay Campbell corresponding author, Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19, CurrCardiol Rep. 2021; 23(11): 168.
Yu CM, Wong RS, Wu EB, Kong S-L, Wong J, Yip GW-K, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006; 82(964):140–4.)
Roy M. John, MBBS, PhD; Saurabh Kumar, BSc(Med)/MBBS, PhD, Sinus Node and Atrial Arrhythmias, (Circulation. 2016; 133:1892-1900. DOI: 10.1161/CIRCULATIONAHA.116.018011.
P A Chiale, M S Halpern, G J Nau, A M Tambussi, J Przybylski, J O Lázzari, M V Elizari, M B Rosenbaum, Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?, American Journal of Cardiovascular Drugs volume 20, pages 413–418 (2020)
H Nägele 1, M Bohlmann, U Eck, B Petersen, W Rödiger, Combination therapy with carvedilol and amiodarone in patients with severe heart failure, Eur J Heart Fail. 2000 Mar; 2(1):71-9. doi:10.1016/s1388-9842(99)00071-9.
Alizadeh,B. , Moavenzadeh Ghaznavi,N. , Alipour,A. and Rahimpour,F. (2024). Atrial Tachycardia and Sinus Node Dysfunction as a Manifestation of a Novel SARS-CoV-2 Infection in a Child: A Rare Case. Iranian Heart Journal, 25(2), 96-101.
MLA
Alizadeh,B. , , Moavenzadeh Ghaznavi,N. , , Alipour,A. , and Rahimpour,F. . "Atrial Tachycardia and Sinus Node Dysfunction as a Manifestation of a Novel SARS-CoV-2 Infection in a Child: A Rare Case", Iranian Heart Journal, 25, 2, 2024, 96-101.
HARVARD
Alizadeh B., Moavenzadeh Ghaznavi N., Alipour A., Rahimpour F. (2024). 'Atrial Tachycardia and Sinus Node Dysfunction as a Manifestation of a Novel SARS-CoV-2 Infection in a Child: A Rare Case', Iranian Heart Journal, 25(2), pp. 96-101.
CHICAGO
B. Alizadeh, N. Moavenzadeh Ghaznavi, A. Alipour and F. Rahimpour, "Atrial Tachycardia and Sinus Node Dysfunction as a Manifestation of a Novel SARS-CoV-2 Infection in a Child: A Rare Case," Iranian Heart Journal, 25 2 (2024): 96-101,
VANCOUVER
Alizadeh B., Moavenzadeh Ghaznavi N., Alipour A., Rahimpour F. Atrial Tachycardia and Sinus Node Dysfunction as a Manifestation of a Novel SARS-CoV-2 Infection in a Child: A Rare Case. Iranian Heart Journal, 2024; 25(2): 96-101.
